Minimal Change Disease: Podocyte Injury With Major Consequences

Clinical Mastery · Visual teaching summary · October 3, 2026

Andrew Bland, MD, FACP, FAAP

Visual summary

Failure to respond as expected should prompt review of diagnosis, adherence, secondary causes, and whether additional pathology is present.

Minimal Change Disease: Podocyte Injury With Major Consequences. Full text follows below.
Download infographic (PNG) · Download Markdown · Read text version ·

Text version

A normal-looking light microscope is not enough

Adult minimal change disease is usually established by kidney biopsy: light microscopy may show little change, while electron microscopy demonstrates podocyte foot-process effacement. Consider FSGS sampling limitations and secondary drug or malignancy associations when the course is atypical.

Recognize the syndrome

Edema, hypoalbuminemia, proteinuria, and sometimes AKI dominate presentation. Adults may need evaluation for drugs, malignancy, and other secondary associations.

Assess complications

Volume imbalance, thrombosis, infection, and medication effects can be consequential. A low serum albumin is not a complete measure of intravascular volume.

Individualize treatment

Disease-specific immunosuppression and supportive care depend on patient context and specialist assessment. Follow response and treatment toxicity together.

Use the relapse pattern to change the discussion

Document complete versus partial remission, relapse timing, and glucocorticoid exposure. Frequent relapse or steroid dependence can justify a steroid-sparing discussion. Persistent nephrotic proteinuria despite an adequate treatment course requires review of adherence, secondary causes, and whether the diagnosis should be revisited.

Revisit unexpected courses

Failure to respond as expected should prompt review of diagnosis, adherence, secondary causes, and whether additional pathology is present.

Continue learning